Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 6/2019

Inhalt (25 Artikel)

Review – Cancer Research

The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer

Jiajing Cai, Qi Qi, Xuemeng Qian, Jia Han, Xinfang Zhu, Qi Zhang, Rong Xia

Review – Cancer Research

Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer

Xiao Zhang, Yukuan Feng, Xi Liu, Jianhui Ma, Yafei Li, Tianzhen Wang, Xiaobo Li

Original Article – Cancer Research

Chemopreventive effect of Callistemon citrinus (Curtis) Skeels against colon cancer induced by 1,2-dimethylhydrazine in rats

Alejandro López-Mejia, Luis Gerardo Ortega-Pérez, Daniel Godinez-Hernández, Blanca Nateras-Marin, Esperanza Meléndez-Herrera, Patricia Rios-Chavez

Original Article – Cancer Research

Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively

Angélica María Gamboa-Cedeño, Mariángeles Castillo, Wenming Xiao, Thomas A. Waldmann, Stella Maris Ranuncolo

Original Article – Cancer Research

Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy

Andreas Buch Møller, Simon Lønbro, Jean Farup, Thomas Schmidt Voss, Nikolaj Rittig, Jakob Wang, Inger Højris, Ulla Ramer Mikkelsen, Niels Jessen

Original Article – Cancer Research

Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration

Abdulhameed Al-Ghabkari, Deema O. Qasrawi, Mana Alshehri, Aru Narendran

Original Article – Cancer Research

IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2

Xiaodong Chen, Feng Chen, Yu Ren, Guobin Weng, Lijun Xu, Xiang Xue, Peter C. Keng, Soo Ok Lee, Yuhchyau Chen

Original Article – Cancer Research

Different statistical techniques dealing with confounding in observational research: measuring the effect of breast-conserving therapy and mastectomy on survival

Marissa C. van Maaren, Saskia le Cessie, Luc J. A. Strobbe, Catharina G. M. Groothuis-Oudshoorn, Philip M. P. Poortmans, Sabine Siesling

Open Access Original Article – Cancer Research

The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy

Erlend Skaga, Ida Ø. Skaga, Zanina Grieg, Cecilie J. Sandberg, Iver A. Langmoen, Einar O. Vik-Mo

Original Article – Cancer Research

TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells

Jinfang Zhu, Weiran Liu, Chen Chen, Hua Zhang, Dongsheng Yue, Chenguang Li, Lianmin Zhang, Liuwei Gao, Yansong Huo, Chang Liu, Giuseppe Giaccone, Bin Zhang, Changli Wang

Review – Clinical Oncology

Research driving innovation: what are key factors for successful integration of translational science into oncology care concepts? 5th European Roundtable Meeting (ERTM) May 4th, 2018, Berlin, Germany

Olaf Ortmann, Julie Torode, Chris Harrison, Johannes Bruns, Ulrike Helbig, Nicolas Philippou, Stefan Schreck, Tit Albreht, Josep Borras, Julie Torode, Jan-Willem Coebergh, Chris Harrison, Johannes Bruns, Ulrike Helbig, Andreas Hochhaus, Monika Klinkhammer-Schalke, Christoph Kowalski, Margarete Landenberger, Katrin Mugele, Olaf Ortmann, Ralf Rambach

Review – Clinical Oncology

Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases

Suheil Albert Atallah-Yunes, Anis John Kadado, Gregory P. Kaufman, Jaime Hernandez-Montfort

Open Access Original Article – Clinical Oncology

Gastrointestinal stromal tumors (GISTs) with remarkable cystic change: a specific subtype of GISTs with relatively indolent behaviors and favorable prognoses

Anwei Xue, Wei Yuan, Xiaodong Gao, Yong Fang, Ping Shu, Chen Xu, He Li, Yifang Xu, Qi Song, Yingyong Hou, Kuntang Shen

Open Access Original Article - Clinical Oncology

First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression

Martin Schuler, Eng-Huat Tan, Kenneth O’Byrne, Li Zhang, Michael Boyer, Tony Mok, Vera Hirsh, James Chih-Hsin Yang, Ki Hyeong Lee, Shun Lu, Yuankai Shi, Sang-We Kim, Janessa Laskin, Dong-Wan Kim, Catherine Dubos Arvis, Karl Kölbeck, Dan Massey, Angela Märten, Luis Paz-Ares, Keunchil Park

Original Article – Clinical Oncology

Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?

Vérane Achard, Sandra Jorcano, Michel Rouzaud, Lluís Escudé, Raymond Miralbell, Thomas Zilli

Original Article – Clinical Oncology

Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia

Jorge E. Cortes, Carlo Gambacorti-Passerini, Michael W. Deininger, Michael J. Mauro, Charles Chuah, Dong-Wook Kim, Dragana Milojkovic, Philipp le Coutre, Valentin Garcia-Gutierrez, Rocco Crescenzo, Carla Mamolo, Arlene Reisman, Andreas Hochhaus, Tim H. Brümmendorf

Original Article – Clinical Oncology

Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma

Nidhi Gupta, Raman Kumar, Tulika Seth, Bhavuk Garg, Hem Chandra Sati, Alpana Sharma

Open Access Original Article – Clinical Oncology

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

Beung-Chul Ahn, Kyoung-Ho Pyo, Chun-Feng Xin, Dongmin Jung, Hyo Sup Shim, Chang Young Lee, Seong Yong Park, Hong In Yoon, Min Hee Hong, Byoung Chul Cho, Hye Ryun Kim

Original Article – Clinical Oncology

Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer

Fan Lian, Wenchuan Chen, Yiming Liu, Long Shen, Wenzhe Fan, Wei Cui, Yue Zhao, Jiaping Li, Yu Wang

Original Article – Clinical Oncology

Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer

Peter G. Hawkins, Yilun Sun, Robert T. Dess, William C. Jackson, Grace Sun, Nan Bi, Muneesh Tewari, James A. Hayman, Gregory P. Kalemkerian, Shirish M. Gadgeel, Theodore S. Lawrence, Randall K. Ten Haken, Martha M. Matuszak, Feng-Ming (Spring) Kong, Matthew J. Schipper, Shruti Jolly

Original Article – Clinical Oncology

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)

Susanne Möbius, Thomas Schenk, Danny Himsel, Jacqueline Maier, Georg-Nikolaus Franke, Susanne Saussele, Christiane Pott, Hajnalka Andrikovics, Nora Meggyesi, Katerina Machova-Polakova, Hana Zizkova, Tomáš Jurcek, Semir Mesanovic, Renata Zadro, Enrico Gottardi, Jens Haenig, Peter Schuld, Nicholas C. P. Cross, Andreas Hochhaus, Thomas Ernst

Original Article – Clinical Oncology

Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva

Fabinshy Thangarajah, Bernd Morgenstern, Caroline Pahmeyer, Lars Mortimer Schiffmann, Julian Puppe, Peter Mallmann, Stefanie Hamacher, Reinhard Buettner, Christina Alidousty, Barbara Holz, Andreas H. Scheel, Anne Maria Schultheis

Open Access Letter to the Editors

Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy

Kosuke Mizutani, Kengo Horie, Taku Kato, Keita Nakane, Kyojiro Kawakami, Yasunori Fujita, Masafumi Ito

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.